Daiichi Life Unit Offers A$11.80 a Share for the 79.5% of Challenger It Doesn't Own

A Japanese insurer that already owns a fifth of Australian investment manager Challenger wants the rest.

TAL Daiichi Life Australia Pty, a unit of Daiichi Life Group, submitted an indicative proposal to buy the roughly 79.5% of Challenger it does not already hold, Challenger told the market on Monday, Oct. 19. The offer is A$11.80 per share. It values Challenger at A$7.94 billion (US$5.53 billion) and the stake Daiichi doesn't own at about A$6.3 billion.

The price

The offer is 19.8% above Challenger's close on Friday, Oct. 16. Against the one-month volume-weighted average price of A$10.03, the premium is 17.7%, according to Challenger's announcement to the Australian Securities Exchange.

Shares jumped more than 15% in Sydney trading to A$11.33 by 2305 GMT, the highest level since Oct. 23, 2018.

The approach is structured as a scheme of arrangement, according to the Australian Financial Review. That is the standard Australian route for a friendly takeover, and it requires shareholder and court approval.

What is and isn't locked in

Nothing is binding. Challenger described the proposal as non-binding and conditional, subject to a number of conditions including satisfactory completion of due diligence and a board recommendation.

Challenger's statement said: "The Board of Challenger is considering the indicative offer."

Daiichi Life issued its own statement confirming that its Australian unit had submitted a non-binding proposal to Challenger's board. The company said no decision has been made on proceeding with a binding transaction.

So there are two decisions still open. Challenger's directors have to decide whether A$11.80 is a price they will recommend. Daiichi has to decide whether to proceed to a binding transaction.

How Daiichi got here

Daiichi's position in Challenger is not new. Through the same unit, it initially acquired a 15.1% minority stake from MS&AD Insurance Group Holdings in April 2025. LSEG data now puts the unit's holding at 20.36%.

The unit operates in Australia under the TAL name, and the bid would hand control of one of the country's larger listed investment managers to a Japanese insurer that has been building its presence in the market through its local arm.

The business being bought

Challenger reported separately that assets under management rose 5% to $31.9 billion in the first quarter of fiscal 2027. The company credited strong sales momentum across domestic and offshore annuities.

The figures landed alongside the takeover news. Challenger's board is considering the offer as it reviews Daiichi's price.

What comes next

If the proposal advances to a binding agreement, Challenger shareholders would receive A$11.80 in cash per share. Until then, the offer is an indication and not a commitment.

The next concrete steps are Challenger's board response and Daiichi's decision on whether to proceed to a binding transaction. Whether the directors will recommend A$11.80 is the open question.